Skip to content

Price / sales at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
11.7×+5.0×
ALN
Alnylam PharmaceuticalsALNY
10.2×-4.6×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
24.8×-26.8×
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
10.6×-12.4×
Royalty Pharma logo
Royalty PharmaRPRX
8.4×+2.5×
AbbVie logo
AbbVieABBV
6.1×-0.3×

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

Based on the most recent quarter.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's price / sales?
Arrowhead Research (ARWR) reported price / sales of 14.1× in Q1 2026.
How has Arrowhead Research's price / sales changed year-over-year?
Arrowhead Research's price / sales increased by 339.9% year-over-year, from 3.2× to 14.1×.
What is the long-term trend for Arrowhead Research's price / sales?
Over 5 years (2020 to 2025), Arrowhead Research's price / sales has grown at a -35.4% compound annual growth rate (CAGR), from 51.2× to 5.7×.
What does price / sales mean?
How many dollars investors pay for each dollar of the company's annual sales.
How do you interpret price / sales?
Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
How does price / sales compare across companies?
Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.